VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 234 filers reported holding VERACYTE INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $906,419 | +53.2% | 40,592 | +74.7% | 0.03% | +54.5% |
| Q2 2023 | $591,795 | -39.1% | 23,235 | -46.7% | 0.02% | -46.3% |
| Q1 2023 | $971,767 | +22.1% | 43,577 | +29.9% | 0.04% | -14.6% |
| Q4 2022 | $795,762 | +67.2% | 33,534 | +17.0% | 0.05% | +60.0% |
| Q3 2022 | $476,000 | +49.2% | 28,660 | +79.0% | 0.03% | +150.0% |
| Q2 2022 | $319,000 | +22.2% | 16,009 | +145.0% | 0.01% | -29.4% |
| Q2 2021 | $261,000 | -17.7% | 6,534 | +10.7% | 0.02% | +6.2% |
| Q1 2021 | $317,000 | +34.3% | 5,900 | +22.4% | 0.02% | +60.0% |
| Q4 2020 | $236,000 | -54.4% | 4,819 | -73.5% | 0.01% | -65.5% |
| Q2 2019 | $518,000 | -80.7% | 18,178 | -83.1% | 0.03% | -82.2% |
| Q1 2019 | $2,690,000 | +412.4% | 107,507 | +157.5% | 0.16% | +288.1% |
| Q4 2018 | $525,000 | +60.6% | 41,755 | +22.0% | 0.04% | +68.0% |
| Q3 2018 | $327,000 | +41.6% | 34,214 | +38.4% | 0.02% | +38.9% |
| Q2 2018 | $231,000 | – | 24,719 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |